The Effects of Direct-to-Consumer Advertising in the Prescription Drug Markets PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Effects of Direct-to-Consumer Advertising in the Prescription Drug Markets PDF full book. Access full book title The Effects of Direct-to-Consumer Advertising in the Prescription Drug Markets by Toshiaki Iizuka. Download full books in PDF and EPUB format.
Author: Toshiaki Iizuka
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The year of 1997 witnessed an important change in direct-to-consumer (DTC) advertising of prescription drugs. For the first time, the Food and Drug Administration (FDA) permitted brand-specific DTC ads on TV without a "brief summary" of comprehensive risk information. This led to a three-fold growth of DTC advertising expenditure in four years, followed by an intensive debate about the effects of DTC advertising on patient and doctor behaviors. This paper empirically examines the effects of DTC ads on ethical drugs by combining 1996-1999 DTC advertising data with the annual National Ambulatory Medical Care Survey (NAMCS). We find that DTC advertising leads to a large increase in the number of outpatient drug visits, a moderate increase in the time spent with doctors, but no effect on doctors' specific choice among prescription drugs within a therapeutic class. Consistent with the proponents' claim, this finding suggests that DTC ads encourage patient visits but do not challenge doctors' authority in the specific choice of prescription drugs. We cannot rule out the possibilities, however, that DTC ads may induce doctors to use prescription drugs over alternative treatments and doctors may spend extra time clarifying DTC ads if they do not prescribe the most advertised drug(s). Our results suggest that the effect of DTC advertising is primarily market-expanding rather than business-stealing, and therefore DTC advertising is a public good for all drugs in the same therapeutic class.
Author: Toshiaki Iizuka
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The year of 1997 witnessed an important change in direct-to-consumer (DTC) advertising of prescription drugs. For the first time, the Food and Drug Administration (FDA) permitted brand-specific DTC ads on TV without a "brief summary" of comprehensive risk information. This led to a three-fold growth of DTC advertising expenditure in four years, followed by an intensive debate about the effects of DTC advertising on patient and doctor behaviors. This paper empirically examines the effects of DTC ads on ethical drugs by combining 1996-1999 DTC advertising data with the annual National Ambulatory Medical Care Survey (NAMCS). We find that DTC advertising leads to a large increase in the number of outpatient drug visits, a moderate increase in the time spent with doctors, but no effect on doctors' specific choice among prescription drugs within a therapeutic class. Consistent with the proponents' claim, this finding suggests that DTC ads encourage patient visits but do not challenge doctors' authority in the specific choice of prescription drugs. We cannot rule out the possibilities, however, that DTC ads may induce doctors to use prescription drugs over alternative treatments and doctors may spend extra time clarifying DTC ads if they do not prescribe the most advertised drug(s). Our results suggest that the effect of DTC advertising is primarily market-expanding rather than business-stealing, and therefore DTC advertising is a public good for all drugs in the same therapeutic class.
Author: United States. General Accounting Office
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 40
Get Book Here
Book Description
Author: United States. Congress. Senate. Special Committee on Aging
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 152
Get Book Here
Book Description
Author: Ray Moynihan
Publisher: Greystone Books
ISBN: 1926706684
Category : Health & Fitness
Languages : en
Pages : 171
Get Book Here
Book Description
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Author:
Publisher: DIANE Publishing
ISBN: 1437986633
Category :
Languages : en
Pages : 8
Get Book Here
Book Description
Author: United States. General Accounting Office
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 24
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Courtney Yarbrough
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Numerous studies have examined the effects of direct-to-consumer advertising (DTC) on patient and physician behaviors; however, none has focused on the relationship between DTC and insurance benefit design. In this study, we explored the impact of DTC advertising on the cost control behaviors of private firms supplying insurance in the Medicare Part D program. We used data from the IMS National Prescription Drug Promotions database and formulary information from Medicare Part D prescription drug plans from the Centers for Medicare and Medicaid Services (CMS) to study the relationship between DTC spending and formulary tier placement, using an instrumental variables estimator to control for the endogeneity of DTC spending. Our results suggest that direct-to-consumer advertising puts pressure on insurers for more favorable formulary placement. Television direct-to-consumer advertising and other measures of manufacturer market power had a significant and negative effect on the likelihood of a branded drug being classified as nonpreferred in formularies. Similarly, we found that when insurers had more market power, branded drugs were more likely to be placed in a nonpreferred formulary tier. We hypothesize that consumers play an important mediating role in the relationship between DTC advertising and insurance coverage for drugs.
Author:
Publisher: DIANE Publishing
ISBN: 1422333035
Category :
Languages : en
Pages : 128
Get Book Here
Book Description
Author: Richard Aaron Hansen
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 588
Get Book Here
Book Description
